Dr Walsh is currently an early-career Assistant Professor at the Goodman Cancer Research Centre (GCRC) and Department of Human Genetics at McGill University, and recently appointed as the Rosalind Goodman Chair in Lung Cancer Research. His interest in understanding responses to immunotherapy comes from his involvement in some of the seminal work in immunogenomics and biomarkers of immune checkpoint inhibitor efficacy from his postdoctoral fellowship in the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center. His lab currently is focuses on using translational genetics and immunogenomics to develop personalized medicine strategies. He is a trained wet-lab biologist who has amassed considerable expertise in bioinformatics. This skill set provides an ideal combination to lead the efforts delineated in his research program. Dr. Walsh strongly believes that by collaborating and combining expertise of clinicians and basic scientists we will have the best chance to develop research models and strategies to help better care for cancer patients.